Endogenous interleukin-1 receptor antagonist is neuroprotective.
about
Inflammation and infection in clinical strokeHIV-1 coat protein gp120 stimulates interleukin-1beta secretion from human neuroblastoma cells: evidence for a role in the mechanism of cell deathThe meteorology of cytokine storms, and the clinical usefulness of this knowledgeMultiple molecular penumbras after focal cerebral ischemia.The neuroimmune-endocrine axis: pathophysiological implications for the central nervous system cytokines and hypothalamus-pituitary-adrenal hormone dynamics.Serum cytokine and glucose levels as predictors of poststroke fatigue in acute ischemic stroke patientsCerebrospinal fluid markers of neuroinflammation in delirium: a role for interleukin-1β in delirium after hip fractureReversible demyelination, blood-brain barrier breakdown, and pronounced neutrophil recruitment induced by chronic IL-1 expression in the brain.Brain interleukin-1β and the intrinsic receptor antagonist control peripheral Toll-like receptor 3-mediated suppression of spontaneous activity in rats.Knockdown of IL-1β improves hypoxia-ischemia brain associated with IL-6 up-regulation in cell and animal modelsInflammatory mechanisms associated with brain damage induced by kainic acid with special reference to the interleukin-1 system.The effect of progesterone dose on gene expression after traumatic brain injuryNeuromodulatory role of endogenous interleukin-1β in acute seizures: possible contribution of cyclooxygenase-2Interleukin-1 and neuronal injury.The type 1 interleukin 1 receptor is not required for the death of murine hippocampal dentate granule cells and microglia activation.Cell therapy centered on IL-1Ra is neuroprotective in experimental stroke.Pharmacogenomics of neuroimmune interactions in human psychiatric disorders.The role of interleukin-1 in neuroinflammation and Alzheimer disease: an evolving perspective.Interleukin-1beta: a bridge between inflammation and excitotoxicity?Cytokine and inducible nitric oxide synthase mRNA expression during experimental murine cryptococcal meningoencephalitis.Comparison of the effects of erythropoietin and anakinra on functional recovery and gene expression in a traumatic brain injury model.Pathways and mechanisms for cytokine signaling of the central nervous system.Fatigue sensation following peripheral viral infection is triggered by neuroinflammation: who will answer these questions?The role of interleukin 1 in acute neurodegeneration and stroke: pathophysiological and therapeutic implications.Increased interleukin-1β levels following low dose MDMA induces tolerance against the 5-HT neurotoxicity produced by challenge MDMA.Ischemic preconditioning-induced neuroprotection is associated with differential expression of IL-1beta and IL-1 receptor antagonist in the ischemic cortex.De novo expression of lipocortin-1 in reactive microglia and astrocytes in kainic acid lesioned rat cerebellum.Activation of the JAK/STAT pathway following transient focal cerebral ischemia: signaling through Jak1 and Stat3 in astrocytes.Interleukin-4, interleukin-10, and interleukin-1-receptor antagonist but not transforming growth factor-beta induce ramification and reduce adhesion molecule expression of rat microglial cells.Interleukin-1 receptor antagonist penetrates human brain at experimentally therapeutic concentrations.Annual review prize lecture cytokines - killers in the brain?Inhibition of the inflammasome complex reduces the inflammatory response after thromboembolic stroke in mice.
P2860
Q28194382-8C553DDF-8D89-4DA3-B282-000805073C2EQ28363800-3ADCC77A-32F0-4E3C-9B38-C60B39014B4BQ33867213-CF273DCA-E32F-468F-833F-050952839BA5Q33977693-2559D3EE-311A-4314-833F-0C22C89D3586Q34044609-524341F5-8896-42DE-B329-4228D8FB476CQ34729401-98839EB4-5309-4DC6-BCBF-22B96D78F4FBQ34760173-49D2843B-CB15-42D6-8EBB-9E75ECA1ADF2Q35103371-5797AA42-A67A-4821-9D54-C91B97352924Q35118685-9BCAC9AA-C056-46D0-91DE-7A464F624A45Q35176253-A0A2D121-19F4-4311-A24F-D24CC2069349Q35202804-9188A0A2-267F-4DB9-B9CA-9ED1A9D60C51Q35212550-166210F2-F8B5-4E60-9BD9-65D68D17C23DQ35574583-703C665D-5750-4FB4-9EB7-B5B24FB5CEF8Q36202191-6EA91534-423E-4231-869E-DA829C3B661AQ36508643-20A76175-2637-44E5-B96C-755112AFA900Q36809420-01D7BF77-53E1-47E8-AC6C-8307E5F20880Q36901407-A4A2B44C-7F11-48FA-BC8D-129C13920549Q37095615-5D557AB1-A276-406D-9FBD-75AC22001A98Q37100241-7AFC27E2-4803-4B11-BC90-F744366EBE8CQ37115803-57EA03E2-08AA-4E0B-88DB-5C5521A695AFQ37233036-8227A6B4-4B40-488C-A90E-143FB2D7F83BQ37376007-CCAEF398-022B-483C-9FB9-A0EFFEE7EA9CQ39490897-E43D0015-8006-4786-9C4C-4FCE2BED40FEQ39794500-28375BB7-51F0-498A-913D-469A1FE6F41FQ41364931-D7A0DD9D-88F0-4D55-8C8D-243DE6A62C34Q41954356-C5569DD4-5F62-4155-88FB-2C443562C5EDQ42473862-378E4366-CF07-484C-8CCC-B5CEB2E18BAAQ42486284-8AC1C8A6-761F-45F0-B077-5191E2EDCFA9Q44059878-EF463CBA-67B1-4E27-AC9A-497692408D1BQ47573293-2AE69C62-DA0C-441A-A87D-F478FDB4D15FQ48341086-A84B3E91-6910-4523-BF2C-638C005C2C0CQ48807829-F7354DBB-9312-422D-9697-1D585A2B8EF8
P2860
Endogenous interleukin-1 receptor antagonist is neuroprotective.
description
1997 nî lūn-bûn
@nan
1997 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Endogenous interleukin-1 receptor antagonist is neuroprotective.
@ast
Endogenous interleukin-1 receptor antagonist is neuroprotective.
@en
Endogenous interleukin-1 receptor antagonist is neuroprotective.
@nl
type
label
Endogenous interleukin-1 receptor antagonist is neuroprotective.
@ast
Endogenous interleukin-1 receptor antagonist is neuroprotective.
@en
Endogenous interleukin-1 receptor antagonist is neuroprotective.
@nl
prefLabel
Endogenous interleukin-1 receptor antagonist is neuroprotective.
@ast
Endogenous interleukin-1 receptor antagonist is neuroprotective.
@en
Endogenous interleukin-1 receptor antagonist is neuroprotective.
@nl
P2093
P356
P1476
Endogenous interleukin-1 receptor antagonist is neuroprotective.
@en
P2093
Bongiorno PB
Loddick SA
Rothwell NJ
P304
P356
10.1006/BBRC.1997.6436
P407
P577
1997-05-01T00:00:00Z